At 7.3% CAGR, Asia Pacific Cranial Implants Market is Projected to be Worth US$ 436.54 Million by 2031, says Business Market Insights 

According to Business Market Insights research, the Asia Pacific cranial implants market was valued at US$ 248.40 million in 2023 and is expected to reach US$ 436.54 million by 2031, registering a CAGR of 7.3% from 2023 to 2031. Surge in elderly populations and advancements in 3D printing with incorporation of original multilayer technology are among the critical factors attributed to driving the Asia Pacific cranial implants market growth.

According to a report published by the Population Division of the United Nations, the geriatric population of the world was ~600 million in 2021, and the number is further expected to reach 2 billion by 2050. As per WHO, by 2030, one in six people worldwide will be 60 years or older. At that time, the population in this age group is projected to increase from 1 billion in 2020 to 1.4 billion. By 2050, the number of people aged 60 and older will double, reaching 2.1 billion. Additionally, the number of individuals aged 80 or older is expected to triple between 2020 and 2050, reaching 426 million. According to the United Nations Economic and Social Commission for Asia and the Pacific (ESCAP), the number of individuals aged 60 and older is projected to more than double from 572 million in 2017 to nearly 1.3 billion by 2050. Older adults are more vulnerable to falls and accidents that raise the risk of head trauma. Aging, coupled with a higher prevalence of neurological diseases, is driving demand for cranial implants. Surgical intervention is often necessary to repair fractured skulls after such injuries, and cranial implants are vital for restoring the skull's structural integrity and protecting the brain. Healthcare systems are focusing on improving the quality of life for older adults, resulting in greater adoption of these implants in trauma and reconstructive surgeries.

On the contrary, the risk of implant failure hampers the growth of Asia Pacific cranial implants market.

By type, the Asia Pacific cranial implants market is segmented into parietal, frontal, occipital, temporal, and sphenoid. The parietal held a 33.1% share of Asia Pacific cranial implants market share in 2023, amassing US$ 82.10 million. It is projected to garner US$ 149.52 million by 2031 to register 7.8% CAGR during 2023–2031.

In terms of material, the Asia Pacific cranial implants market is segmented into polymethyl methacrylate, polyether ether ketone, titanium, and others. The polyether ether ketone held 44.4% share of Asia Pacific cranial implants market share in 2023, amassing US$ 110.17 million. It is projected to garner US$ 194.92 million by 2031 to register 7.4% CAGR during 2023–2031.

Based on end user, the Asia Pacific cranial implants market is segmented into hospitals, trauma centers, and others. The hospitals held 59.9% share of Asia Pacific cranial implants market share in 2023, amassing US$ 148.73 million. It is projected to garner US$ 271.66 million by 2031 to register 7.8% CAGR during 2023–2031.

Based on country, the Asia Pacific cranial implants market is categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Our regional analysis states that China captured 27.7% share of Asia Pacific cranial implants market in 2023. It was assessed at US$ 68.72 million in 2023 and is likely to hit US$ 123.72 million by 2031, registering a CAGR of 7.6% during 2023–2031.

Key players operating in the cranial implants market are Stryker Corp, Zimmer Biomet Holdings Inc, Integra LifeSciences Holdings Corp, OsteoMed SA, Anatomics Pty Ltd, Matrix Surgical Holdings LLC, Calavera Surgical, Medtronic Plc, Xilloc Medical BV, Johnson & Johnson, evonos GmbH & Co. KG, B Braun SE, UAB Ortho Baltic, 3D Systems Corp, GPC Medical Ltd, Bioplate Inc, EUROS SAS, Biocomposites Ltd, Medprin Biotech GmbH, Kelyniam Global Inc, MedCAD, KLS Martin Group, and Longeviti Neuro Solutions LLC, among others.

• On April-2024: Kelyniam Global and Fin-ceramica, Faenza S.p.a., makers of custom cranial implants, announced the launch of the NEOS Surgery Cranial LOOP fixation system has received 510(k) clearance from the FDA for use with Finceramica's Customized Bone hydroxyapatite cranial implant.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com